News
Latest News, Announcements, and Press Releases
07Nov 18
Codexis to Present at Two Investment Conferences in November
REDWOOD CITY, Calif. , Nov. 07, 2018 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that management will present at two upcoming investment conferences: 9 th Annual Craig-Hallum Alpha Select Conference on Thursday, November 15,…
read more01Nov 18
Codexis to Hold Third Quarter 2018 Conference Call on November 8
REDWOOD CITY, Calif. , Nov. 01, 2018 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that it will report third quarter 2018 financial results after market close on Thursday, November 8, 2018 . Codexis management…
read more01Oct 18
Codexis Appoints Claus Ladefoged to Global Enzyme Business Development Role
REDWOOD CITY, Calif. , Oct. 01, 2018 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces the appointment of Claus Ladefoged as Director, Enzyme Business Development . Ladefoged has extensive experience in successfully building relationships and
read more11Sep 18
National Association For Business Resources Announces San Francisco Bay Area’s Best And Brightest Companies To Work For® Winners
Codexis is pleased to announce we’ve been selected as one of the nation’s Best and Brightest Companies to Work For®. September 11, 2018 – San Francisco, CA — Companies that excel at employee relations, use innovation to motivate employees, implement…
read more29Aug 18
Codexis to Present at Three Investment Conferences in September
REDWOOD CITY, Calif. , Aug. 29, 2018 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that management will present at three upcoming investment conferences: H.C. Wainwright 20 th Annual Global investment Conference on Wednesday, September 5,…
read more08Aug 18
Codexis Reports Second Quarter 2018 Financial Results
Total revenues increase 31% to $13.5 million driven by higher R&D revenue Phase 1a clinical trial for CDX-6114 initiated Conference call begins at 4:30 p.m. Eastern time today REDWOOD CITY, Calif. , Aug. 08, 2018 (GLOBE NEWSWIRE) — Codexis, Inc.…
read more01Aug 18
Codexis to Hold Second Quarter 2018 Conference Call on August 8
REDWOOD CITY, Calif. , Aug. 01, 2018 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that it will report second quarter 2018 financial results after market close on Wednesday, August 8, 2018 . Codexis management…
read more11Jul 18
Codexis Appoints Dr. Hicham Alaoui, Veteran Drug Discoverer, as Vice President, Biotherapeutics Research & Development
REDWOOD CITY, Calif. , July 11, 2018 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces the appointment of Hicham Alaoui , Ph.D. to the newly created position of Vice President, Biotherapeutics Research & Development . The…
read more09Jul 18
Codexis Doses First Subjects in Phase 1a Trial of CDX-6114
REDWOOD CITY, Calif. , July 09, 2018 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that it has dosed the first subjects in a first-in-human Phase 1a
read more29May 18
Codexis to Present at Three Upcoming Investment Conferences
REDWOOD CITY, Calif. , May 29, 2018 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that management will present at three upcoming investment conferences: 15 th Annual Craig-Hallum Institutional Investor Conference on Wednesday, May 30 ,…
read moreSince 2002, Codexis has created new technologies to unlock the power of proteins®. Put our unmatched protein engineering expertise to work for you.
Unlock the power of proteins® with Codexis
Learn More
Company
Industries